Search research articles
Contact Us
Filters
Showing results (1-10 of 27) with videos related to
Page
of 3
Sort By:
Cureus
|
October 20, 2025
Curettage and Artificial Bone Graft Using Chevron Osteotomy for Bone Tumor of the Talus: A Report of Three Cases
Yoshiro Yoshikawa, Hiromichi Oshiro, Yuta Miyashi, et al.
Anticancer Research
|
December 31, 2024
Relationship Between <sup>18</sup>F-FDG-PET/CT-derived Tumor Glucose Metabolic Activity, Nutritional Risk, and Survival in Patients With Soft-tissue Sarcoma
Hiromichi Oshiro, Kohei Mizuta, Yuta Miyashi, et al.
In Vivo (Athens, Greece)
|
October 30, 2025
Heterogeneity of Tumor Glucose Metabolism in Schwannomas Between Trunk and Extremities: An Imaging Study
Yuta Miyashi, Hiromichi Oshiro, Yoshiro Yoshikawa, et al.
Anticancer Research
|
April 28, 2026
Sulfasalazine an Inhibitor of System x<sub>C</sub> <sup>-</sup> (Cystine/glutamate Antiporter), Combined With Recombinant Methioninase, Inhibits Both Cancer and Normal Cells, Suggesting Lack of Cancer Selectivity of Cysteine Restriction
Jinsoo Kim, Qinghong Han, Shukuan Li, et al.
Frontiers in Oncology
|
June 19, 2026
Direct comparison of efficacy of combining ivermectin versus five first-line chemotherapy drugs with recombinant methioninase against colon-cancer cells
Jinsoo Kim, Qinghong Han, Shukuan Li, et al.
Anticancer Research
|
January 30, 2026
Lack of Cancer Specificity of Methionine Adenosyltransferase 2A (MAT2A) Inhibitor AG-270 in Combination With Recombinant Methioninase <i>In Vitro</i>
Jinsoo Kim, Qinghong Han, Shukuan Li, et al.
Cancer Diagnosis & Prognosis
|
May 4, 2026
The Combination of Methionine Adenosyltransferase 2A (MAT2A) Inhibitor AG-270 and Recombinant Methioninase Is Not Cancer-selective in a Co-culture Model of Colon Cancer Cells and Normal Fibroblasts
Jinsoo Kim, Qinghong Han, Shukuan Li, et al.
Anticancer Research
|
November 29, 2025
The Combination of Recombinant Methioninase and Low-dose Chloroquine Selectively Eradicates Colon-Cancer Cells Without Apparent Toxicity on Co-cultured Normal Fibroblasts
Jinsoo Kim, Qinghong Han, Shukuan Li, et al.
Anticancer Research
|
December 30, 2025
Effect of Recombinant Methioninase Dose and Timing on the Selective and Precise Elimination of Cancer Cells from Co-Cultured Normal Cells and on Methionine-dependent Rescue of Cancer Cells
Jinsoo Kim, Qinghong Han, Shukuan Li, et al.
Anticancer Research
|
October 28, 2025
Simultaneous Targeting of Multiple Hallmarks of Cancer With Recombinant Methioninase, Rapamycin and Chloroquine Is Specific and Synergistic to MiaPaCa-2 Pancreatic-Cancer Cells in Contrast to Hs-27 Normal Fibroblasts
Jinsoo Kim, Qinghong Han, Shukuan Li, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 27) with videos related to
Sort By:
Page
of 3
Cureus
|
October 20, 2025
Curettage and Artificial Bone Graft Using Chevron Osteotomy for Bone Tumor of the Talus: A Report of Three Cases
Yoshiro Yoshikawa, Hiromichi Oshiro, Yuta Miyashi, et al.
Anticancer Research
|
December 31, 2024
Relationship Between <sup>18</sup>F-FDG-PET/CT-derived Tumor Glucose Metabolic Activity, Nutritional Risk, and Survival in Patients With Soft-tissue Sarcoma
Hiromichi Oshiro, Kohei Mizuta, Yuta Miyashi, et al.
In Vivo (Athens, Greece)
|
October 30, 2025
Heterogeneity of Tumor Glucose Metabolism in Schwannomas Between Trunk and Extremities: An Imaging Study
Yuta Miyashi, Hiromichi Oshiro, Yoshiro Yoshikawa, et al.
Anticancer Research
|
April 28, 2026
Sulfasalazine an Inhibitor of System x<sub>C</sub> <sup>-</sup> (Cystine/glutamate Antiporter), Combined With Recombinant Methioninase, Inhibits Both Cancer and Normal Cells, Suggesting Lack of Cancer Selectivity of Cysteine Restriction
Jinsoo Kim, Qinghong Han, Shukuan Li, et al.
Frontiers in Oncology
|
June 19, 2026
Direct comparison of efficacy of combining ivermectin versus five first-line chemotherapy drugs with recombinant methioninase against colon-cancer cells
Jinsoo Kim, Qinghong Han, Shukuan Li, et al.
Anticancer Research
|
January 30, 2026
Lack of Cancer Specificity of Methionine Adenosyltransferase 2A (MAT2A) Inhibitor AG-270 in Combination With Recombinant Methioninase <i>In Vitro</i>
Jinsoo Kim, Qinghong Han, Shukuan Li, et al.
Cancer Diagnosis & Prognosis
|
May 4, 2026
The Combination of Methionine Adenosyltransferase 2A (MAT2A) Inhibitor AG-270 and Recombinant Methioninase Is Not Cancer-selective in a Co-culture Model of Colon Cancer Cells and Normal Fibroblasts
Jinsoo Kim, Qinghong Han, Shukuan Li, et al.
Anticancer Research
|
November 29, 2025
The Combination of Recombinant Methioninase and Low-dose Chloroquine Selectively Eradicates Colon-Cancer Cells Without Apparent Toxicity on Co-cultured Normal Fibroblasts
Jinsoo Kim, Qinghong Han, Shukuan Li, et al.
Anticancer Research
|
December 30, 2025
Effect of Recombinant Methioninase Dose and Timing on the Selective and Precise Elimination of Cancer Cells from Co-Cultured Normal Cells and on Methionine-dependent Rescue of Cancer Cells
Jinsoo Kim, Qinghong Han, Shukuan Li, et al.
Anticancer Research
|
October 28, 2025
Simultaneous Targeting of Multiple Hallmarks of Cancer With Recombinant Methioninase, Rapamycin and Chloroquine Is Specific and Synergistic to MiaPaCa-2 Pancreatic-Cancer Cells in Contrast to Hs-27 Normal Fibroblasts
Jinsoo Kim, Qinghong Han, Shukuan Li, et al.
Page
of 3